These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11801288)

  • 21. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors.
    Overstreet DH; Knapp DJ; Breese GR
    Pharmacol Biochem Behav; 2004 Feb; 77(2):405-13. PubMed ID: 14751471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to an antisense oligonucleotide decreases corticotropin-releasing factor receptor binding in rat pituitary cultures.
    Owens MJ; Mulchahey JJ; Kasckow JW; Plotsky PM; Nemeroff CB
    J Neurochem; 1995 May; 64(5):2358-61. PubMed ID: 7722522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
    Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
    Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.
    Contarino A; Dellu F; Koob GF; Smith GW; Lee KF; Vale W; Gold LH
    Brain Res; 1999 Jul; 835(1):1-9. PubMed ID: 10448190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grin1 deletion in CRF neurons sex-dependently enhances fear, sociability, and social stress responsivity.
    Gilman TL; DaMert JP; Meduri JD; Jasnow AM
    Psychoneuroendocrinology; 2015 Aug; 58():33-45. PubMed ID: 25938741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
    Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
    Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.
    Conti LH; Costello DG; Martin LA; White MF; Abreu ME
    Pharmacol Biochem Behav; 1994 Jun; 48(2):497-503. PubMed ID: 8090821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats.
    Schwetz I; McRoberts JA; Coutinho SV; Bradesi S; Gale G; Fanselow M; Million M; Ohning G; Taché Y; Plotsky PM; Mayer EA
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G704-12. PubMed ID: 15994424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
    Cipriano AC; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats.
    Heinrichs SC; Joppa M
    Behav Brain Res; 2001 Jul; 122(1):43-50. PubMed ID: 11287075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior.
    Heinrichs SC; Lapsansky J; Lovenberg TW; De Souza EB; Chalmers DT
    Regul Pept; 1997 Jul; 71(1):15-21. PubMed ID: 9299637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.
    Zorrilla EP; Valdez GR; Nozulak J; Koob GF; Markou A
    Brain Res; 2002 Oct; 952(2):188-99. PubMed ID: 12376179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
    Lu L; Liu D; Ceng X
    Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge.
    Nguyen NK; Keck ME; Hetzenauer A; Thoeringer CK; Wurst W; Deussing JM; Holsboer F; Müller MB; Singewald N
    Psychopharmacology (Berl); 2006 Oct; 188(3):374-85. PubMed ID: 16953386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of corticotropin-releasing factor receptor type 2 in the bed nucleus of stria terminalis improves posttraumatic stress disorder-like symptoms in a model of incubation of fear.
    Elharrar E; Warhaftig G; Issler O; Sztainberg Y; Dikshtein Y; Zahut R; Redlus L; Chen A; Yadid G
    Biol Psychiatry; 2013 Dec; 74(11):827-36. PubMed ID: 23871471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related alterations in emotional behaviors and amygdalar corticotropin-releasing factor (CRF) and CRF-binding protein expression in aged Fischer 344 rats.
    Pisarska M; Mulchahey JJ; Welge JA; Geracioti TD; Kasckow JW
    Brain Res; 2000 Sep; 877(2):184-90. PubMed ID: 10986331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfactory neophobia and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain corticotropin releasing factor.
    Pascual J; Heinrichs SC
    Epilepsia; 2007 Apr; 48(4):827-33. PubMed ID: 17381443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze.
    Vicentini JE; Céspedes IC; Nascimento JO; Bittencourt JC; Viana MB
    Horm Behav; 2014 Mar; 65(3):195-202. PubMed ID: 24472740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.